scorecard

You Searched For "Alzheimer s" and got 20 results


Sort By:


Business Insider Latest Story Image
4 mins read

The FDA just approved a new Alzheimer's drug that's set to be a blockbuster

The new drug, called Leqembi, slowed the rate of cognitive decline in Alzheimer's patients by 27%.

Yeji Jesse Lee   


Business Insider Latest Story Image
4 mins read

Incredible medical breakthroughs of 2022, from treating blood cancer to slowing Alzheimer's disease

A vaccine for RSV and a drug that may slow the progression of Alzheimer's disease are among the gre…

Catherine Schuster-Bruce   


Business Insider Latest Story Image
2 mins read

New Alzheimer's drug slows cognitive decline, clinical trial finds

Lecanemab, a drug made by Eisai and Biogen, was observed in a large-scale trial to have slowed the …

Cheryl Teh   


Business Insider Latest Story Image
2 mins read

The Mediterranean diet may reduce your risk of Alzheimer's thanks to staples like leafy greens and nuts, study finds

People who eat more leafy greens have healthier brains, the equivalent nearly two decades younger t…

Gabby Landsverk   


Business Insider Latest Story Image
4 mins read

A 6-year-old has a rare disease that his mom calls Parkinson's mixed with Alzheimer's. His family hopes a scientific miracle can save his life.

Léo Vauclare was 2 when he got a diagnosis of a rare genetic disease. The life expectancy is five t…

Jane Ridley   


Business Insider Latest Story Image
3 mins read

The promising new Alzheimer's drugs to watch — and the far-out ideas that could reshape how we treat the disease

Two Alzheimer's drugs, Biogen's Leqembi and Eli Lilly's donanemab, treat the disease by focusing on…

Yeji Jesse Lee   


Business Insider Latest Story Image
3 mins read

An experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly

In a late-stage trial, Eli Lilly's experimental Alzheimer's treatment slowed the rate of cognitive …

Yeji Jesse Lee   


Business Insider Latest Story Image
2 mins read

Esme Mazzeo   


Business Insider Latest Story Image
2 mins read

Leah Rosenbaum   


Business Insider Latest Story Image
4 mins read

We read through the 45-page congressional investigation into Biogen's Alzheimer's drug. Here are the 3 most shocking takeaways.

The investigation found that Biogen knew the drug's hefty price tag would make the medication inacc…

Yeji Jesse Lee,Leah Rosenbaum   


Business Insider Latest Story Image
3 mins read

As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer's

Scientist David Liu has developed two ways to edit human DNA. He's testing whether they can be used…

Allison DeAngelis   


Business Insider Latest Story Image
2 mins read

Police say a woman stole $600,000 from her husband and tried to cover it up by convincing him that he had Alzheimer's

Donna Marino was arrested last week in Connecticut and charged with first-degree grand larceny and …

Lauren Frias   


Business Insider Latest Story Image
2 mins read

A small drugmaker's stock tumbles 30% after a lawyer questions its experimental Alzheimer's treatment

Cassava is a lesser-known meme stock that surged 910% at one point on optimism for its early-stage …

Shalini Nagarajan   


Business Insider Latest Story Image
4 mins read

This Alzheimer’s drug slowed cognitive decline in some patients. Analysts say it could become a blockbuster hit.

Full results of Biogen and Eisai's Alzheimer's study on lecanemab give some credence to a controver…

Yeji Jesse Lee   


Business Insider Latest Story Image
3 mins read

Virtual reality could help ward off Alzheimer's by making people feel less lonely

Virtual reality could reduce loneliness, a key risk factor for Alzheimer's. It could also trigger o…

Aria Bendix   


Business Insider Latest Story Image
2 mins read

Katie Balevic   


Business Insider Latest Story Image
2 mins read

Biogen sinks 10% after Medicare limits coverage of new Alzheimer's drug Aduhelm

Medicare seeks to only cover patients who are enrolled in clinical trials evaluating Aduhelm, a dru…

Carla Mozée   


Business Insider Latest Story Image
3 mins read

Medicare sticks by decision to limit coverage of a controversial Alzheimer's drug to people involved in clinical trials

The Medicare coverage decision is a blow for Biogen, which has struggled with sales of its new drug…

Allison DeAngelis   


Business Insider Latest Story Image
2 mins read

Biogen soars 43% after its Alzheimer's drug helps slow down cognitive decline in late-stage study

JPMorgan estimates the Alzheimer's drug could generate between $6 billion and $10 billion in peak s…

Matthew Fox   


Business Insider Latest Story Image
2 mins read

Chris Hemsworth just found out he has a high risk of Alzheimer's, and says watching his grandfather's dementia was 'heartbreaking'

Chris Hemsworth said he learned about his high risk of Alzheimer's while filming, and it prompted h…

Gabby Landsverk